FDA Brief

Warning letters Food

FDA warning letter to

Ng Zheng Inc. DBA Kwan Sang Noodle Company

High riskIssued Apr 23, 2024Posted May 14, 2024Division of Human and Animal Food Operations West IV

FDA warns Denver noodle maker over allergen, pathogen, pest and sanitation failures and missing food facility registration.

What happened

FDA inspected the Denver facility from September 18 to October 23, 2023 and found failures in food safety manufacturing rules. The inspection found undeclared allergens, allergen cross-contact on shared equipment, gaps in controlling germs on ready-to-eat noodles, pests, and insanitary conditions. FDA also found the facility was not registered with FDA.

What FDA found

  1. The company did not treat undeclared wheat and egg as a hazard for its non-ready-to-eat noodle products and distributed unlabeled bags of noodles that contain wheat and/or egg.

    21 CFR 117.130(a)(1)
  2. The company did not carry out its allergen cross-contact controls on shared equipment; egg dough residue remained after cleaning and no monitoring records were provided.

    21 CFR 117.135(a)(1)
  3. The company did not analyze or control environmental pathogen risks for ready-to-eat noodles, and employees handled non-food surfaces then packed noodles without changing gloves or washing.

    21 CFR 117.130(a); 21 CFR 117.165(a)(3)
  4. The company did not review supplier certificates of analysis for mold toxins in wheat flour and did not show that suppliers were approved.

    21 CFR 117.410(c)
  5. Employees with soiled aprons, towels, and bare forearms touched ready-to-eat noodles; cooling tables touched a dirty wall; floors were cracked; and cockroaches were found in production areas.

    21 CFR 117.10(b); 21 CFR 117.20(b)(1); 21 CFR 117.35(a); 21 CFR 117.35(c)
  6. The facility was not registered with FDA as required.

    Section 415 of the Act [21 U.S.C. ยง 350d]; 21 CFR Part 1, Subpart H

What FDA wants

FDA tells the company to register the facility immediately and to reply in writing within 15 working days with the specific corrective steps, supporting documents, and a schedule for any actions not finished.

Who should pay attention

  • retailers and restaurants that buy noodles onsite from this firm
  • food companies that rely on shared equipment for allergen control
  • buyers of ready-to-eat foods who depend on supplier hazard controls

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. CNC Noodle Corporation

    FDA warned CNC Noodle Corporation that its Hayward, California noodle plant had insanitary conditions, no pathogen or allergen controls, and mislabeled products.

    High risk
  2. ABC Food Corp

    ABC Food Corp's ready-to-eat rice noodles and tofu were made without required hazard analysis and preventive controls.

    High risk
  3. Dough-To-Go, Inc.

    FDA warned Dough-To-Go of Santa Clara, CA after an inspection found insanitary conditions and unused food safety controls at its baked goods plant.

    High risk
  4. Hearthy Foods, Inc.

    FDA cited Hearthy Foods after an inspection for CGMP violations in RTE whey protein and dietary supplements, including allergen and pest issues.

    High risk